Literature DB >> 6109080

Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6109080

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Pleuropulmonary and retroperitoneal fibrosis associated with bromocriptine treatment.

Authors:  C D Ward; J Thompson; M D Humby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

2.  Bromocriptine induced pleuropulmonary fibrosis.

Authors:  J Wiggins; C Skinner
Journal:  Thorax       Date:  1986-04       Impact factor: 9.139

Review 3.  A risk-benefit assessment of drugs used in the management of Parkinson's disease.

Authors:  I Y Bodagh; D R Robertson
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

Review 4.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.